Intraosseous basivertebral nerve ablation: Pooled long-term outcomes from two prospective clinical trials
At three years post-Intracept Procedure, statistically significant (p<0.0001) improvements of 31.2 points and 4.3 points were observed compared to baseline, for mean Oswestry Disability Index (ODI) and mean numeric pain score (NPS), respectively. The study also found that 74% fewer patients were actively using opioid medications for low back pain and 84% fewer patients required spinal injections for the same pain source and treatment level at three years following treatment.
Intraosseous BVNA demonstrates statistically significant, clinically meaningful, and durable improvements in pain and function through 3 years in patients with primary vertebrogenic low back pain. BVNA-treated patients significantly reduced opioid use and interventions for low back pain. To read the study go to ScienceDirect.com
More to explorer
Emotional Awareness, Expression Therapy Shown to Curb Pain Severity
Facebook A randomized clinical trial’s results suggest that emotional awareness and expression therapy (EAET) “may be a preferred intervention for medically and psychiatrically complex
Psychosocial Distress May Be Best Indicator of High-Impact Chronic Pain With KOA
Facebook Data published in the Journal of Pain indicate that high-impact chronic pain (HICP) is more common among people with knee osteoarthritis (KOA)
Trim the Fat, Reduce the Pain?
Facebook A first-of-its-kind study has found a link between carrying extra fat in the gut and widespread chronic pain, with reductions in